MENU
CADL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Candel Therapeutics (CADL) Ownership - Who owns Candel Therapeutics?
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer... Show more
Profile
Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
42
Web
https://www.candeltx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
215.87M
P/E Ratio
N/A
Total Cash
102.65M
Projected Growth
N/A
Total Debt
13.47M
Revenue
N/A
Risk (Beta)
-1.22
Dividend Yield
N/A
Total Cash/Share
2.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CADL
Capitalization
216M
P/E Ratio
N/A
Risk (Beta)
-1.22
Dividend Yield
N/A
Total Cash
103M
Total Cash/Share
2.17
Total Debt
13.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
66.3M
P/B Ratio
3.25
Cash Flow
N/A
Earnings
-1.74
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
469K
Current Ratio
2.77
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-52.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-74.53
Shares Held By Institutions
241M
Shares Outstanding - Current
47.2M
Total Liabilities
40.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
-47.350
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
42
Web
https://www.candeltx.com